Pages that link to "Q43034904"
Jump to navigation
Jump to search
The following pages link to Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial (Q43034904):
Displaying 50 items.
- Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials (Q21245273) (← links)
- Ribavirin plus interferon versus interferon for chronic hepatitis C (Q24240879) (← links)
- Ribavirin plus interferon versus interferon for chronic hepatitis C (Q24244070) (← links)
- Ribavirin: Past, present and future (Q26775002) (← links)
- Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system (Q27472717) (← links)
- Synergistic In Vitro Interactions between Alpha Interferon and Ribavirin against Bovine Viral Diarrhea Virus and Yellow Fever Virus as Surrogate Models of Hepatitis C Virus Replication (Q27477551) (← links)
- Clinical guidelines on the management of hepatitis C (Q27477946) (← links)
- Replicative Homeostasis III: implications for antiviral therapy and mechanisms of response and non-response (Q27478215) (← links)
- Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo (Q27480732) (← links)
- Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy (Q27481007) (← links)
- Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis (Q28074783) (← links)
- The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels (Q28344154) (← links)
- Mechanism of action of interferon and ribavirin in treatment of hepatitis C (Q29619805) (← links)
- High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin (Q33209400) (← links)
- Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials (Q33234511) (← links)
- WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C. (Q33291074) (← links)
- NMR studies of p7 protein from hepatitis C virus (Q33499741) (← links)
- Renal manifestations of hepatitis C infection (Q33586586) (← links)
- Secondary structure, dynamics, and architecture of the p7 membrane protein from hepatitis C virus by NMR spectroscopy (Q33667920) (← links)
- Efficacy and tolerability of combination therapy with interferon-alfa plus ribavirin in patients with chronic hepatitis C virus infection: a single-center study in relapsers and nonresponders to previous treatment with high-dose interferon-alfa mono (Q33739046) (← links)
- Comparison of the chronic effects of ribavirin and caffeic acid phenethyl ester (CAPE) on pancreatic damage and hepatotoxicity (Q33756297) (← links)
- Clinical implications of hepatitis C viral kinetics (Q33809452) (← links)
- Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus (Q33852451) (← links)
- Pathogenesis, diagnosis and management of hepatitis C. (Q33870245) (← links)
- Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling (Q33899320) (← links)
- Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. (Q33940495) (← links)
- Pre- and post-transplant treatment of hepatitis C. (Q33988139) (← links)
- Ribavirin enhances IFN-α signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV. (Q34082923) (← links)
- Treatment of hepatitis C virus infection (Q34099424) (← links)
- Predictors of a favorable response to alpha interferon therapy for hepatitis C. (Q34210693) (← links)
- Current and future therapies of hepatitis C. (Q34269634) (← links)
- Management of interferon therapy nonresponders (Q34422694) (← links)
- The kinetics of hepatitis C virus infection (Q34422746) (← links)
- New therapeutic strategies for hepatitis C. (Q34490190) (← links)
- Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial (Q34624732) (← links)
- Fluvastatin inhibits hepatitis C replication in humans (Q34769764) (← links)
- Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV. (Q34789841) (← links)
- Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C. (Q34799396) (← links)
- Treatment of recurrent hepatitis C. (Q34936164) (← links)
- Ribavirin monotherapy increases sustained response rate in relapsers of end treatment virologic responders (Q35011394) (← links)
- Polyethylene glycol-interferon: current status in hepatitis C virus therapy (Q35020845) (← links)
- Current treatment of choice for chronic hepatitis C infection (Q35026621) (← links)
- Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells (Q35047714) (← links)
- Effect of ribavirin alone or combined with silymarin on carbon tetrachloride induced hepatic damage in rats (Q35161778) (← links)
- Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma (Q35177569) (← links)
- Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents (Q35546564) (← links)
- Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection. (Q35748913) (← links)
- Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK). (Q35772046) (← links)
- Bupropion for treatment of interferon-induced depression (Q35776758) (← links)
- Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions (Q35802787) (← links)